| Assessment of the novel T-cell activation marker–tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study D Portevin, F Moukambi, P Clowes, A Bauer, M Chachage, NE Ntinginya, ... The Lancet infectious diseases 14 (10), 931-938, 2014 | 163 | 2014 |
| Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a … CD Tweed, R Dawson, DA Burger, A Conradie, AM Crook, CM Mendel, ... The Lancet Respiratory Medicine 7 (12), 1048-1058, 2019 | 137 | 2019 |
| Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis JS Zifodya, JS Kreniske, I Schiller, M Kohli, N Dendukuri, SG Schumacher, ... Cochrane Database of Systematic Reviews, 2021 | 132 | 2021 |
| Xpert MTB/RIF Ultra assay for the diagnosis of pulmonary tuberculosis in children: a multicentre comparative accuracy study I Sabi, A Rachow, D Mapamba, P Clowes, NE Ntinginya, M Sasamalo, ... Journal of Infection 77 (4), 321-327, 2018 | 85 | 2018 |
| Pharmacokinetics, tolerability, and bacteriological response of rifampin administered at 600, 900, and 1,200 milligrams daily in patients with pulmonary tuberculosis RE Aarnoutse, GS Kibiki, K Reither, HH Semvua, F Haraka, CM Mtabho, ... Antimicrobial agents and chemotherapy 61 (11), 10.1128/aac. 01054-17, 2017 | 84 | 2017 |
| A bundle of services increased ascertainment of tuberculosis among HIV-infected individuals enrolled in a HIV cohort in rural sub-Saharan Africa F Haraka, TR Glass, G Sikalengo, A Gamell, A Ntamatungiro, C Hatz, ... PloS one 10 (4), e0123275, 2015 | 39 | 2015 |
| Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis F Haraka, M Kakolwa, SG Schumacher, RR Nathavitharana, ... Cochrane Database of Systematic Reviews, 2021 | 27 | 2021 |
| Pulmonary aspergilloma: a treatment challenge in sub-Saharan Africa C Pohl, L Jugheli, F Haraka, E Mfinanga, K Said, K Reither PLoS neglected tropical diseases 7 (10), e2352, 2013 | 20 | 2013 |
| Limited value of whole blood Xpert® MTB/RIF for diagnosing tuberculosis in children C Pohl, LK Rutaihwa, F Haraka, M Nsubuga, F Aloi, NE Ntinginya, ... Journal of Infection 73 (4), 326-335, 2016 | 14 | 2016 |
| Chronic airflow obstruction in Tanzania–a cross-sectional study T Zoller, EH Mfinanga, TB Zumba, PJ Asilia, EM Mutabazi, ... BMC pulmonary medicine 18, 1-8, 2018 | 11 | 2018 |
| Maturation and Mip-1β production of cytomegalovirus-specific T cell responses in Tanzanian children, adolescents and adults: impact by HIV and mycobacterium tuberculosis co … D Portevin, F Moukambi, M Mpina, A Bauer, F Haraka, M Chachage, ... PloS one 10 (5), e0126716, 2015 | 11 | 2015 |
| Impact of diagnostic test Xpert MTB/RIF® on health outcomes for tuberculosis F Haraka, RR Nathavitharana, SG Schumacher, M Kakolwa, ... The Cochrane Database of Systematic Reviews 2018 (2), 2018 | 10 | 2018 |
| Increasing TB/HIV Case Notification through an Active Case-Finding Approach among Rural and Mining Communities in Northwest Tanzania SM Abeid R, Mergenthaler C , Muzuka V, Goodluck A, Nkwabi T, Bigio J ... Journal of tropical medicine, 2022 | 8 | 2022 |
| Factors affecting HIV counselling and testing among adults in Muheza District, Tanzania F Haraka, A Mohamed, G Kilonzo, H Shao Tanzania Journal of Health Research 14 (1), 2012 | 7 | 2012 |
| Mycobacterium intracellulare infection in non-HIV infected patient in a region with a high burden of tuberculosis F Haraka, LK Rutaihwa, M Battegay, K Reither Case Reports 2012, bcr0120125713, 2012 | 6 | 2012 |
| Effect of history of tuberculosis on specificity of Xpert MTB/RIF F Haraka, SG Schumacher, A Ross, A Mantsoki, S Gagneux, K Reither, ... European Respiratory Journal 56 (3), 2020 | 5 | 2020 |
| Factors affecting motivation among key populations to engage with tuberculosis screening and testing Services in Northwest Tanzania: a mixed-methods analysis RA Khaji, VM Kabwebwe, AG Mringo, TF Nkwabi, J Bigio, C Mergenthaler, ... International Journal of Environmental Research and Public Health 18 (18), 9654, 2021 | 3 | 2021 |
| Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially … M Cevik, LC Thompson, C Upton, VC Rolla, M Malahleha, B Mmbaga, ... The Lancet Infectious Diseases, 2024 | 1 | 2024 |
| Symptoms and functional limitations related to respiratory health and carbon monoxide poisoning in Tanzania: a cross sectional study T Zoller, EH Mfinanga, TB Zumba, PJ Asilia, EM Mutabazi, ... Environmental health 21 (1), 38, 2022 | 1 | 2022 |
| Novel diagnostic procedure: Mycobacterium intracellulare infection in non-HIV infected patient in a region with a high burden of tuberculosis F Haraka, LK Rutaihwa, M Battegay, K Reither BMJ Case Reports 2012, 2012 | 1 | 2012 |
